2000-2012乐山市梅毒流行病学特征分析

目的了解乐山市2000-2012年梅毒发病情况及流行病学特征,为制定防治策略和措施提供科学依据。方法采用描述流行病学方法,用SPSS10.0软件统计处理。结果2000-2012年全市共报告梅毒3809例,年平均发病率8.90/10万;发病率逐年上升,从2000年的0.55/10万上升到2012年的21.68/10万,年均递增41.13%;胎传梅毒比例从6.74%上升到42.32%。梅毒与AIDS/HIV关系密切(r=0.80,P0.01)。结论乐山市梅毒处于快速增长期,应采取加强性病防治知识宣传、提倡安全性行为、加强重点人群监测及规范诊治等综合措施,以控制梅毒的流行。     

重庆市男男性行为者商业性性活动及影响因素分析

目的 了解重庆市男男性行为者(MSM)发生商业性性活动的基本情况及影响因素.方法 于2019-2020年应用方便抽样的方法在重庆市招募1 151名MSM,采用自填式问卷方法收集社会人口学特征、性行为特征、毒品使用史等;采集调查对象静脉血5 mL进行抗艾滋病病毒(HIV)检测和梅毒螺旋体抗体检测.采用二分类多因素Logi...     

15055例拟受血者血液传播疾病血清指标的分析

目的探讨拟受血者输血前各项血液传播性疾病血清标志物情况。方法对15 055例拟受血者血液传播疾病血清指标进行分析,采用酶联免疫吸附试验(ELISA)对拟受血者进行丙型肝炎病毒抗体(抗-HCV)和人类免疫缺陷病毒抗体(抗-HIV)检测;梅毒螺旋体(抗-TP)检测采用ELISA、明胶颗粒凝集试验和快速血浆反应素环状卡片试验(RPR)3种方法检测。结果抗-HCV阳性率为1.67%,抗-HIV阳性率0.03%。单独ELISA检测抗-TP阳性、ELISA和RPR检测抗-TP均阳性、单独RPR检测抗-TP阳性率分别为2.76%、0.58%和0.03%。15例同时抗-HCV和抗-TP阳性。结论做好输血前血液传播疾病检测,不仅可以了解该地区血源性疾病的感染情况,还可减少和避免医疗纠纷及医源性感染,保证医患双方的合法权益。     

化学发光微粒子免疫分析法筛查梅毒螺旋体特异性抗体的临床研究

目的：用化学发光微粒子免疫分析法（CM IA ）联合梅毒螺旋体明胶凝集试验（T PPA ）和甲苯胺红不加热血清试验（TRUST）检测梅毒抗体（TP-Ab）,探讨CMIA在筛查梅毒螺旋体特异性抗体中的临床应用价值。方法采用CMIA对住院和门诊患者进行TP-Ab筛查,阳性标本再进行TPPA和TRUST 的检测,对比分析3种检测方法的检验结果的符合率。结果25030例血清标本经CM IA筛查共检出T P-Ab阳性732例,检出率为2．9％。以TPPA和TRUST对阳性标本进行联合检测的阳性检出率分别为78．7％、37．2％。以 TPPA为标准参考方法, CM IA S/CO在1～＜9的阳性符合率为29．7％～90．1％,S/CO≥9的阳性符合率为100．0％。结论 CM IA可取代传统的非密螺旋体抗原血清试验用于高通量梅毒抗体的筛查。     

Surveillance and epidemiology of syphilis,gonorrhoea and chlamydia in the non-European Union countries of the World Health Organization European Region, 2015 to 2020

BackgroundEpidemics of sexually transmitted infections (STI) are a major public health challenge in the World Health Organization (WHO) European Region.AimWe aimed to provide an overview of case reporting and other surveillance data for syphilis, gonorrhoea and chlamydia for the non-European Union (EU)/European Economic Area (EEA) countries of the Centre and East part of the WHO European Region as per classification used by the WHO Regional Office for Europe (WHO/Europe) and the European Centre for Disease Prevention and Control.MethodsData were provided by the surveillance agencies of the Member States for the period 2015 to 2019 through the WHO/Europe Communicable Diseases Annual Reporting Form. We analysed reported cases, explored data reported to the WHO Gonococcal Antimicrobial Surveillance Programme (GASP) and performed a review of publications on antimicrobial resistance (AMR) in gonorrhoea in the period 2015 to 2020 using systematic methodology.ResultsFrom 2015 to 2019, in most of the countries with three or more data points, there was a pattern of decrease in reported syphilis, gonorrhoea and chlamydia cases, which is in contrast to the EU/EEA. The number of reported cases per 100,000 population was 0.4–26.5 for syphilis, 0–18.5 for gonorrhoea and 0–43.3 for chlamydia. Four countries reported recent data on AMR in gonorrhoea to GASP, and we identified further publications from Georgia, Russia and Ukraine.ConclusionWe found wide heterogeneity in reported rates of STI. There is a strong need to improve availability and quality of STI surveillance data in the non-EU/EEA countries.     

不同孕期治疗妊娠梅毒对妊娠结局的影响

目的:明确不同孕期妊娠梅毒患者的治疗对妊娠结局的影响。方法:共124例妊娠梅毒妇女接受了驱梅治疗,包括孕早期42例,孕中期40例,孕晚期42例。结果:124例妊娠梅毒患者中不良妊娠33例,包括流产死产14例,先天性梅毒患儿19例。孕早期不良妊娠率为7.14%,孕中期为22.5%,孕晚期为50%,三组比较差异有统计学意义(P0.05)。结论:妊娠梅毒患者治疗越早,不良妊娠发生率越低。     

不同滴度的妊娠梅毒患者的治疗结局分析

目的:探讨不同滴度的妊娠梅毒治疗后对治疗结局的分析。方法:回顾性分析2014年1月至2016年9月于我科治疗的120名妊娠梅毒患者作为本次试验的研究对象。将选取的120名妊娠梅毒患者根据妊娠梅毒确诊时的甲苯胺红不加热血清试验(TRUST滴度)的不同分为三组:分别为妊娠梅毒确诊时TRUST滴度小于1∶4、妊娠梅毒确诊时TRUST滴度1∶4~1∶8、妊娠梅毒确诊时TRUST滴度1∶8以上。TRUST滴度小于1∶4组患者30例,TRUST滴度1∶4~1∶8组患者50例,TRUST滴度1∶8以上组患者40例。然后对各组患者的妊娠结局进行统计学分析。结果:TRUST滴度<1∶4组自然流产1例(3.3%)、宫内死胎1例(3.3%)、早产儿2例(6.7%)、新生儿先天性梅毒1例(3.3%),不良妊娠结局的发生率为16.7%;TRUST滴度1∶4~1∶8组自然流产5例(10%)、宫内死胎3例(6%)、早产儿5例(10%)、新生儿先天性梅毒5例(10%),不良妊娠结局的发生率为36%;TRUST滴度>1∶8组自然流产5例(12.5%)、宫内死胎4例(10%)、早产儿8例(20%)、新生儿先天性梅毒7例(17.5%),不良妊娠结局的发生率为60%。结论:妊娠梅毒不同滴度的患者治疗结局不同,妊娠梅毒滴度越高不良妊娠结局的发生率越高。     

Accuracy and precision of using partial-mouth recordings to study the prevalence,extent and risk associations of untreated periodontitis

ObjectiveTo study the accuracy and precision of estimating the prevalence, extent and associated risks of untreated periodontitis using partial-mouth recording protocols (PRPs) Methods: A purposive sample of 431 individuals who had never been treated for periodontal disease was recruited from screening clinics at the King Saud bin Abdul-Aziz University for Health Sciences. Data were collected using questionnaires and clinical examinations. The prevalence, extent and risk associations of periodontitis were evaluated. Three PRPs were compared to full-mouth recordings (FRPs) in terms of the sensitivity, specificity, predictive values, and absolute bias. Results: The prevalence of periodontitis was estimated with the highest accuracy and precision by examinations of the full mouth at the mesiobuccal and distolingual sites (FM)MB-DL, followed by random half-mouth (RHM) recordings. The extent of periodontitis was estimated with high precision using all the PRPs, and the absolute bias ranged from ?0.6 to ?2.3. The absolute bias indicated by OR for risk associations was small for the three PRPs and ranged from ?0.8 to 0.8. Conclusion: (FM)MB-DL and RHM were the PRPs with moderate to high levels of accuracy and precision for estimating the prevalence and risk associations of periodontitis. The extent of periodontitis was estimated with high precision using all three PRPs. The results of this study showed that the magnitude and direction of bias were associated with the severity of periodontitis, the selected PRPs and the magnitude of the risk associations.     

12例神经梅毒临床症状与疗效分析

目的:评估抗梅毒治疗对神经梅毒患者的临床疗效.方法:回顾性分析2017年6月至2019年9月期间在我科住院的12例神经梅毒患者,对比治疗前后血RPR滴度及脑脊液白细胞计数、蛋白量、RPR滴度,评估治疗前后患者病情是否改善.结果:12例患者治疗后血RPR滴度从5.50±1.98下降至4.25±1.87,差异有统计学意义(...     

昆明市HIV/梅毒共感染病例晚发现情况及其影响因素研究

目的 了解昆明市艾滋病病毒(HIV)和梅毒共感染者的晚发现率及其影响因素.方法 统计2005-2018年"中国疾病预防控制信息系统"中昆明市报告的HIV/梅毒共感染者晚发现比例,运用x2检验分析晚发现率的变化趋势,采用Logistic回归对其影响因素进行相关分析.结果 862例研究对象平均年龄(36.77±0.474)...